{"id": "1357481575278120962", "creation": 1612483802.0, "user_id": "1457469324", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Recipients of new intranasal vaccine designed to spur antibodies to hemagglutinin exhibit promising #immuneresponse. This #vaccine platform  has potential in use against #HIV and #COVID19.\n\nPubl. in @jclinicalinvest\n\n#pandemic #SARSCoV2 #virus\n\nhttps://t.co/Lhl7xEWAZK", "first_save": 1634559108.199414, "hashtags": ["#IMMUNERESPONSE", "#VACCINE", "#HIV", "#COVID19", "#PANDEMIC", "#SARSCOV2", "#VIRUS"]}